Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Creatine for the Treatment of Depression
Brent M. Kious, Douglas G. Kondo, Perry F. Renshaw
Biomolecules (2019) Vol. 9, Iss. 9, pp. 406-406
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Creatine in Health and Disease
Richard B. Kreider, Jeffrey R. Stout
Nutrients (2021) Vol. 13, Iss. 2, pp. 447-447
Open Access | Times Cited: 129
Effects of Creatine Supplementation on Brain Function and Health
Scott C. Forbes, Dean M. Cordingley, Stephen M. Cornish, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 921-921
Open Access | Times Cited: 80
Preliminary evidence should be treated as such: Response to “Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?”
Riccardo De Giorgi, Nima Norbu Sherpa, Edoardo G. Ostinelli
European Neuropsychopharmacology (2025) Vol. 93, pp. 15-16
Closed Access | Times Cited: 2
New insights into the cellular activities of Fndc5/Irisin and its signaling pathways
Farzaneh Rabiee, Liana Lachinani, Sarvenaz Ghaedi, et al.
Cell & Bioscience (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 126
Novel drug developmental strategies for treatment‐resistant depression
Éva Borbély, Mária Simon, Eberhard Fuchs, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 6, pp. 1146-1186
Open Access | Times Cited: 69
“Heads Up” for Creatine Supplementation and its Potential Applications for Brain Health and Function
Darren G. Candow, Scott C. Forbes, Sergej M. Ostojić, et al.
Sports Medicine (2023) Vol. 53, Iss. S1, pp. 49-65
Open Access | Times Cited: 30
Mitochondria in depression: The dysfunction of mitochondrial energy metabolism and quality control systems
Mengruo Jiang, Liyuan Wang, Hui Sheng
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 15
Creatine supplementation is safe, beneficial throughout the lifespan, and should not be restricted
Richard B. Kreider, Andrew R. Jagim, Jose Antonio, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access | Times Cited: 1
Nutrition and bipolar disorder: a systematic review
Fernanda C. Gabriel, Manoela Lima Oliveira, Bruna De Martino Martella, et al.
Nutritional Neuroscience (2022) Vol. 26, Iss. 7, pp. 637-651
Closed Access | Times Cited: 31
Creatine Supplementation in Children and Adolescents
Andrew R. Jagim, Chad M. Kerksick
Nutrients (2021) Vol. 13, Iss. 2, pp. 664-664
Open Access | Times Cited: 34
Role of Creatine Supplementation in Conditions Involving Mitochondrial Dysfunction: A Narrative Review
Robert Percy Marshall, Jan-Niklas Droste, Jürgen Gießing, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 529-529
Open Access | Times Cited: 24
Irisin: A promising treatment for neurodegenerative diseases
Jingyu Qi, Liu-kun Yang, Xin‐shang Wang, et al.
Neuroscience (2022) Vol. 498, pp. 289-299
Closed Access | Times Cited: 23
Focus on brain-lung crosstalk: Preventing or treating the pathological vicious circle between the brain and the lung
Xiaoqiu Li, Jie Deng, Yu Long, et al.
Neurochemistry International (2024) Vol. 178, pp. 105768-105768
Closed Access | Times Cited: 5
Effects of Creatine Supplementation on Properties of Muscle, Bone, and Brain Function in Older Adults: A Narrative Review
Scott C. Forbes, Darren G. Candow, Luís Henrique Boiko Ferreira, et al.
Journal of Dietary Supplements (2021) Vol. 19, Iss. 3, pp. 318-335
Closed Access | Times Cited: 29
Creatine Supplementation for Patients with Inflammatory Bowel Diseases: A Scientific Rationale for a Clinical Trial
Theo Wallimann, Caroline Hall, Sean P. Colgan, et al.
Nutrients (2021) Vol. 13, Iss. 5, pp. 1429-1429
Open Access | Times Cited: 29
Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects
Miguel Ángel Alvarez-Mon, Miguel Á. Ortega, Cielo García‐Montero, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 821-821
Open Access | Times Cited: 29
A mitochondrial nexus in major depressive disorder: Integration with the psycho-immune-neuroendocrine network
M.T. Ciubuc-Batcu, Nicolas J. C. Stapelberg, John P. Headrick, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166920-166920
Open Access | Times Cited: 12
Testosterone synthesis was inhibited in the testis metabolomics of a depression mouse model
Guanghui Chen, Wenbin Zhang, Dongyan Li, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 627-635
Closed Access | Times Cited: 4
Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area
Nima Norbu Sherpa, Riccardo De Giorgi, Edoardo G. Ostinelli, et al.
European Neuropsychopharmacology (2024) Vol. 90, pp. 28-35
Open Access | Times Cited: 4
Biochemical changes in subregions of the cingulate gyrus in patients with post-COVID syndrome
А. Г. Труфанов, I. A. Voznyuk, Anna Kutkova, et al.
The European Physical Journal Special Topics (2025)
Closed Access
Creatina, el suplemento de moda en deportistas, ¿útil en insuficiencia cardiaca?
Dámaris Carballeira Puentes, David Dobarro, María Melendo‐Viu
REC CardioClinics (2025)
Closed Access
Creatine as a treatment for depression: A brain bioenergetics perspective
Nicholas Fabiano, Brendon Stubbs
European Neuropsychopharmacology (2025) Vol. 96, pp. 3-4
Closed Access
Elevating the level of hypoxia inducible factor may be a new potential target for the treatment of depression
Ilhyang Kang, Douglas G. Kondo, Jungyoon Kim, et al.
Medical Hypotheses (2020) Vol. 146, pp. 110398-110398
Closed Access | Times Cited: 28
Differential and spatial expression meta-analysis of genes identified in genome-wide association studies of depression
Wennie Wu, Derek Howard, Etienne Sibille, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Pterostilbene as a Therapeutic Alternative for Central Nervous System Disorders: A Review of the Current Status and Perspectives
Xin Qu, Lijuan Zhang, Lin Wang
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 40, pp. 14432-14457
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top